Comstock, Timothy L <br/><br/>
Safety and tolerability of loteprednol etabonate 0.5% and tobramycin 0.3% ophthalmic suspension in pediatric subjects.  [electronic resource] 

 -  Paediatric drugs  Apr 2012 
 - 119-30 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1179-2019 
<br/><br/><label>Standard No.: </label>10.2165/11596320-000000000-00000  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androstadienes--administration & dosage<br/>Anti-Allergic Agents--administration & dosage<br/>Anti-Bacterial Agents--administration & dosage<br/>Child<br/>Child, Preschool<br/>Conjunctivitis--chemically induced<br/>Double-Blind Method<br/>Drug Eruptions--etiology<br/>Eyelids--drug effects<br/>Female<br/>Fever--chemically induced<br/>Humans<br/>Incidence<br/>Infant<br/>Infant, Newborn<br/>Inflammation--chemically induced<br/>Intraocular Pressure--drug effects<br/>Loteprednol Etabonate<br/>Male<br/>Multicenter Studies as Topic<br/>Ophthalmic Solutions--adverse effects<br/>Safety<br/>Tobramycin--administration & dosage<br/>Vision, Ocular--drug effects<br/>Visual Acuity--drug effects